BR112023019790A2 - Métodos e composições para geração de células progenitoras de oligodendrócitos - Google Patents

Métodos e composições para geração de células progenitoras de oligodendrócitos

Info

Publication number
BR112023019790A2
BR112023019790A2 BR112023019790A BR112023019790A BR112023019790A2 BR 112023019790 A2 BR112023019790 A2 BR 112023019790A2 BR 112023019790 A BR112023019790 A BR 112023019790A BR 112023019790 A BR112023019790 A BR 112023019790A BR 112023019790 A2 BR112023019790 A2 BR 112023019790A2
Authority
BR
Brazil
Prior art keywords
progenitor cells
methods
oligodendrocyte progenitor
compositions
opcs
Prior art date
Application number
BR112023019790A
Other languages
English (en)
Portuguese (pt)
Inventor
Nooshin Amini
Original Assignee
Trailhead Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trailhead Biosystems Inc filed Critical Trailhead Biosystems Inc
Publication of BR112023019790A2 publication Critical patent/BR112023019790A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0622Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0623Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/385Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/41Hedgehog proteins; Cyclopamine (inhibitor)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/415Wnt; Frizzeled
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases [EC 2.]
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112023019790A 2021-03-30 2022-01-28 Métodos e composições para geração de células progenitoras de oligodendrócitos BR112023019790A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163168065P 2021-03-30 2021-03-30
PCT/US2022/014306 WO2022211893A1 (en) 2021-03-30 2022-01-28 Methods and compositions for generating oligodendrocyte progenitor cells

Publications (1)

Publication Number Publication Date
BR112023019790A2 true BR112023019790A2 (pt) 2023-11-07

Family

ID=80446173

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023019790A BR112023019790A2 (pt) 2021-03-30 2022-01-28 Métodos e composições para geração de células progenitoras de oligodendrócitos

Country Status (10)

Country Link
US (4) US12385009B2 (https=)
EP (1) EP4314256A1 (https=)
JP (1) JP2024511880A (https=)
KR (1) KR20230161494A (https=)
CN (1) CN117321191A (https=)
AU (1) AU2022247250A1 (https=)
BR (1) BR112023019790A2 (https=)
CA (1) CA3215398A1 (https=)
IL (1) IL305671A (https=)
WO (1) WO2022211893A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022247250A1 (en) 2021-03-30 2023-11-09 Trailhead Biosystems Inc. Methods and compositions for generating oligodendrocyte progenitor cells
US20250304916A1 (en) 2024-03-11 2025-10-02 Trailhead Biosystems Inc. Methods and compositions for generating vascular leptomeningeal cells

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2028268A1 (en) 2007-08-20 2009-02-25 Université Libre De Bruxelles Generation of neuronal cells from pluripotent stem cells
US8227247B2 (en) * 2007-12-20 2012-07-24 Wisconsin Alumni Research Foundation Method of generating myelinating oligodendrocytes
DK2980209T3 (en) 2011-05-20 2018-04-23 Mclean Hospital Corp NEURONAL PROGENITOR CELLS AND APPLICATIONS
WO2013163228A1 (en) 2012-04-24 2013-10-31 International Stem Cell Corporation Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells
JP6541577B2 (ja) * 2013-02-06 2019-07-10 ユニバーシティー オブ ロチェスター ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞
CA2899507A1 (en) 2013-03-14 2014-09-25 The Regents Of The University Of California In vitro production of medial ganglionic eminence precursor cells
EP3031908B1 (en) 2013-08-06 2018-12-05 Takeda Pharmaceutical Company Limited Method for producing dopaminergic neurons
WO2015069736A1 (en) 2013-11-08 2015-05-14 The Mclean Hospital Corporation METHODS FOR EFFICIENT GENERATION OF GABAergic INTERNEURONS FROM PLURIPOTENT STEM CELLS
ES2939807T3 (es) 2014-03-21 2023-04-27 Fujifilm Cellular Dynamics Inc Producción de neuronas dopaminérgicas del mesencéfalo y métodos para su utilización
PL3145517T3 (pl) 2014-05-22 2021-04-06 New York Stem Cell Foundation, Inc. Funkcjonalne oligodendrocyty pochodzące z pluripotencjalnych komórek macierzystych oraz sposoby ich otrzymywania i stosowania
WO2016103269A1 (en) 2014-12-23 2016-06-30 Ramot At Tel-Aviv University Ltd. Populations of neural progenitor cells and methods of producing and using same
JP6998772B2 (ja) 2015-04-09 2022-02-04 ビオラミナ アーベー 神経変性疾患の処置における使用のための幹細胞由来のドパミン作用性細胞を生成するための方法および組成物
US10973930B2 (en) 2016-02-18 2021-04-13 The Penn State Research Foundation Generating GABAergic neurons in brains
KR101870240B1 (ko) 2016-04-12 2018-06-22 서울대학교산학협력단 지방줄기세포에서 신경줄기세포, 신경세포 및 가바성 신경세포로의 분화 유도 방법
GB201610748D0 (en) 2016-06-20 2016-08-03 Koninklijke Nederlandse Akademie Van Wetenschappen Improved diffrentation method
JP2020519237A (ja) 2017-04-13 2020-07-02 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ヒトオリゴデンドロサイトを作製しインビトロでの髄鞘形成を研究するための個別化された神経系3d培養系
US11702629B2 (en) 2017-05-08 2023-07-18 Regents Of The University Of Minnesota Acceleration of stem cell differentiation
US12365872B2 (en) 2018-09-19 2025-07-22 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture
CN110042082B (zh) 2019-04-19 2020-11-27 安徽中盛溯源生物科技有限公司 视网膜色素上皮细胞及其制备方法和应用
WO2020219696A1 (en) * 2019-04-26 2020-10-29 The Regents Of The University Of California Devices and methods for generating oligodendrocyte progenitor cells
EP4021477A4 (en) 2019-08-29 2023-12-13 Memorial Sloan Kettering Cancer Center METHOD FOR GENERATING AND ISOLATING MID-DOPAMINE NEURONS
CN115151633A (zh) 2019-12-09 2022-10-04 威斯康星校友研究基金会 多潜能干细胞衍生的多巴胺能亚型神经元祖细胞的体外扩增
GB202006792D0 (en) 2020-05-07 2020-06-24 Ericson Lars Johan Method and uses thereof
AU2022247250A1 (en) 2021-03-30 2023-11-09 Trailhead Biosystems Inc. Methods and compositions for generating oligodendrocyte progenitor cells
US20230027059A1 (en) 2021-07-19 2023-01-26 Trallhead Biosystems Inc. Methods and compositions for generating human midbrain neural progenitor cells
CN113564122B (zh) 2021-08-05 2022-04-08 呈诺再生医学科技(珠海横琴新区)有限公司 人诱导性多能干细胞向少突胶质细胞分化的方法,试剂盒以及应用
WO2023075913A1 (en) 2021-10-29 2023-05-04 Trailhead Biosystems Inc. Methods and compositions for generating human forebrain neural progenitor cells and for maturation thereof to parvalbumin+ interneurons
JP2025524856A (ja) 2022-07-21 2025-08-01 トレイルヘッド バイオシステムズ インコーポレイテッド 神経前駆細胞からヒト中脳ドーパミン作動性ニューロンを作製するための方法および組成物
KR20250047348A (ko) 2022-08-08 2025-04-03 트레일헤드 바이오시스템즈 인크. 희소돌기아교세포 전구 세포를 생성하기 위한 방법 및 조성물

Also Published As

Publication number Publication date
CN117321191A (zh) 2023-12-29
WO2022211893A1 (en) 2022-10-06
CA3215398A1 (en) 2022-10-06
AU2022247250A1 (en) 2023-11-09
US12385009B2 (en) 2025-08-12
US20260055366A1 (en) 2026-02-26
JP2024511880A (ja) 2024-03-15
US20220315891A1 (en) 2022-10-06
US20240158744A1 (en) 2024-05-16
WO2022211893A9 (en) 2022-12-08
EP4314256A1 (en) 2024-02-07
US20240158743A1 (en) 2024-05-16
IL305671A (en) 2023-11-01
KR20230161494A (ko) 2023-11-27

Similar Documents

Publication Publication Date Title
BR112022017216A2 (pt) Método para produzir células exterminadoras naturais a partir de células-tronco pluripotentes
BR112023018844A2 (pt) Composições e métodos para geração de células t gama-delta de células-tronco pluripotentes induzidas
BR112013026501A2 (pt) “métodos para preparar um oócito, de fertilização in vitro, e para aumentar a capacidade de geração de atp de um oócito, oócito, e, composição”
NZ609731A (en) Compositions of adult organ stem cells and uses thereof
WO2010059876A3 (en) In vitro human b lymphopoiesis culture system
BR112013002811A8 (pt) meios básicos simplificados para cultura celular pluripotente de humano
MX350951B (es) Composiciones y metodos para tratar enfermedades retinales.
CO2019002569A2 (es) Método para aislar células madre mesenquimales a partir de membrana amniótica de cordón umbilical utilizando un medio de cultivo celular
AR051527A1 (es) Planta transformada que expresa una dextranosucrasa y sintetiza un almidon modificado
MX382080B (es) Método para cultivar células eucariónticas.
MX356756B (es) Células madre pluripotentes en microportadores.
BR112022008056A2 (pt) Método para preparar exossomas derivados de células-tronco mesenquimais e solução de cultura produzida a partir do mesmo
MX350966B (es) Celulas madre pluripotentes.
BR112014006176A8 (pt) Rna transcrito in vitro ou rna sintético, composição, método para gerar uma população de células t geneticamente modificadas por rna, e, uso de uma célula t geneticamente modificada
SG195299A1 (en) Expansion of stem cells in hollow fiber bioreactors
MX2010002426A (es) Agente para promover la adhesion de las celulas del endotelio corneal.
BR112023019790A2 (pt) Métodos e composições para geração de células progenitoras de oligodendrócitos
AR069894A1 (es) Plantas con mayor rendimiento produciendo un knock out (silenciamiento) en genes relacionados con la eficiencia en el uso de nitrogeno (ko nue)"
BR112022021613A2 (pt) Métodos para gerar células tímicas in vitro
BR112021024657A2 (pt) Célula de bacillus não esporulada, uso da referida célula, oligossacarídeo fucosilado, bem como o método para a produção e uso do mesmo e composição nutricional
BR112021026002A2 (pt) Regeneração e transformação melhorada de plantas com a ajuda de um gene de reforço grf1
MX2015000188A (es) Metodo para producir iduronato-2-sulfatasa recombinante.
CL2010000774A1 (es) Medio para el cultivo de celulas de mamiferos que comprende ademas de los nutrientes habituales de los medios de cultivo basales para cultivo de celulas de mamiferos, sobrenadante de la fraccion ii+iii del plasma humano segun el metodo de cohn; procedimiento de preparacion; y su uso.
BR112022018640A2 (pt) Métodos para produzir uma população de células compreendendo cardiomiócitos e para purificar cardiomiócitos, população de células contendo cardiomiócitos, e, agente para terapia de transplante de células
WO2021250583A3 (en) 3d culture of mesenchymal lineage precursor or stem cells